This page in English

Lisen Arnheim Dahlström



  • 1999 Kandidatexamen i biomedicin med mikrobiologi som huvudämne, Manchester Metropolitan University, England
  • 2005 Doktorsexamen i Smittskydd, Karolinska Institutet


Min forskning fokuserar främst på att förbättra metoder för att förebygga livmoderhalscancer och att utvärdera vacciners säkerhet och effektivitet.

Handledning av doktorander


Authors' response: Letter to the Editor - HPV vaccine and autoimmunity
Grönlund O, Herweijer E, Sundström K, Arnheim-dahlström L
Journal of internal medicine 2016;():-

Autoantibody targets in vaccine-associated narcolepsy
Häggmark-månberg A, Zandian A, Forsström B, Khademi M, Lima Bomfim I, Hellström C, et al
Autoimmunity 2016;49(6):421-433

Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study
Grönlund O, Herweijer E, Sundström K, Arnheim-dahlström L
Journal of internal medicine 2016;280(6):618-626

Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial
Elfgren K, Elfström Km, Naucler P, Arnheim-dahlström L, Dillner J
American journal of obstetrics and gynecology 2016;():-

No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination
Lamb F, Ploner A, Fink K, Maeurer M, Bergman P, Piehl F, et al
PloS one 2016;11(4):e0154296-

Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study
Herweijer E, Sundström K, Ploner A, Uhnoo I, Sparén P, Arnheim-dahlström L
International journal of cancer 2016;138(12):2867-74

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study
Wang J, Andrae B, Sundström K, Ström P, Ploner A, Elfström Km, et al
BMJ (Clinical research ed.) 2016;352():i276-

Sexually transmitted infections after bereavement - a population-based cohort study
Bond E, Lu D, Herweijer E, Sundström K, Valdimarsdóttir U, Fall K, et al
BMC infectious diseases 2016;16(1):419-

A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden
Feltelius N, Persson I, Ahlqvist-rastad J, Andersson M, Arnheim-dahlström L, Bergman P, et al
Journal of internal medicine 2015;278(4):335-53

Cervical cancer screening in Europe: Quality assurance and organisation of programmes
Elfström Km, Arnheim-dahlström L, Von Karsa L, Dillner J
European journal of cancer (Oxford, England : 1990) 2015;51(8):950-68

Incidence of herpes zoster and associated events including stroke--a population-based cohort study
Sundström K, Weibull Ce, Söderberg-löfdal K, Bergström T, Sparén P, Arnheim-dahlström L
BMC infectious diseases 2015;15():488-

Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases
Ambati A, Poiret T, Svahn Bm, Valentini D, Khademi M, Kockum I, et al
Journal of internal medicine 2015;278(3):264-76

Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer
Sundström K, Ploner A, Arnheim-dahlström L, Eloranta S, Palmgren J, Adami Ho, et al
Journal of the National Cancer Institute 2015;107(10):-

Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial
Elfström Km, Smelov V, Johansson Al, Eklund C, Naucler P, Arnheim-dahlström L, et al
International journal of cancer 2015;136(2):350-9

Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: A 14-year follow-up of a randomized primary HPV screening trial
Smelov V, Elfstrom Km, Johansson Alv, Eklund C, Naucler P, Arnheim-dahlstrom L, et al

Organization and quality of HPV vaccination programs in Europe
Elfström Km, Dillner J, Arnheim-dahlström L
Vaccine 2015;33(14):1673-81

Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous System
Scheller Nm, Svanstrom H, Pasternak B, Arnheim-dahlstrom L, Sundstrom K, Fink K, et al

The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study
Herweijer E, Feldman Al, Ploner A, Arnheim-dahlström L, Uhnoo I, Netterlid E, et al
PloS one 2015;10(7):e0134185-

A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010
Lind A, Ramelius A, Olsson T, Arnheim-dahlström L, Lamb F, Khademi M, et al
Journal of autoimmunity 2014;50():99-106

Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma
Herweijer E, Leval A, Ploner A, Eloranta S, Simard Jf, Dillner J, et al
JAMA 2014;311(6):597-603

Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review
Elfström Km, Herweijer E, Sundström K, Arnheim-dahlström L
Current opinion in oncology 2014;26(1):120-9

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe
Romio S, Weibel D, Dieleman Jp, Olberg Hk, De Vries Cs, Sammon C, et al
PloS one 2014;9(1):e82222-

Human papillomavirus (HPV) vaccination and subsequent sexual behaviour: evidence from a large survey of Nordic women
Hansen Bt, Kjær Sk, Arnheim-dahlström L, Liaw Kl, Jensen Ke, Thomsen Lt, et al
Vaccine 2014;32(39):4945-53

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
Elfström Km, Smelov V, Johansson Al, Eklund C, Nauclér P, Arnheim-dahlström L, et al
BMJ (Clinical research ed.) 2014;348():g130-

Number of human papillomavirus vaccine doses and condyloma--reply
Ploner A, Herweijer E, Arnheim-dahlström L
JAMA 2014;311(23):2439-40

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study
Arnheim-dahlström L, Pasternak B, Svanström H, Sparén P, Hviid A
BMJ (Clinical research ed.) 2013;347():f5906-

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines
Dodd Cn, Romio Sa, Black S, Vellozzi C, Andrews N, Sturkenboom M, et al
Vaccine 2013;31(40):4448-58

Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer
Sundström K, Ploner A, Dahlström La, Palmgren J, Dillner J, Adami Ho, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013;22(1):150-8

Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study
Leval A, Herweijer E, Ploner A, Eloranta S, Fridman Simard J, Dillner J, et al
Journal of the National Cancer Institute 2013;105(7):469-74

The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns
Wijnans L, Lecomte C, De Vries C, Weibel D, Sammon C, Hviid A, et al
Vaccine 2013;31(8):1246-54

A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark
Vaesco Consortium, Andrews N, Stowe J, Miller E, Svanstrom H, Johansen K, et al
VACCINE 2012;30(19):3042-6

Awareness and Knowledge of Human Papillomavirus in the Swedish Adult Population
Dahlstrom La, Sundstrom K, Young C, Lundholm C, Sparen P, Tran Tn

Guillain-Barre Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccine: Multinational Self Controlled Case Series Study in Europe
Weibel D, Romio S, Dieleman Jp, De Vries Cs, Sammon C, Andrews N, et al

Incidence of Genital Warts in Sweden Before and After Quadrivalent Human Papillomavirus Vaccine Availability
Leval A, Herweijer E, Arnheim-dahlstrom L, Walum H, Frans E, Sparen P, et al

Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study
Arnheim-dahlström L, Hällgren J, Weibull Ce, Sparén P
BMJ (Clinical research ed.) 2012;345():e7594-

Assessing Perceived Risk and STI Prevention Behavior: A National Population-Based Study with Special Reference to HPV
Leval A, Sundstrom K, Ploner A, Dahlstrom La, Widmark C, Sparen P
PLOS ONE 2011;6(6):e20624-

Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe
Vaesco-gbs Case-control Study Grp, Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, et al

Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer
Dahlstrom La, Andersson K, Luostarinen T, Thoresen S, Ogmundsdottir H, Tryggvadottir L, et al

Safety of Adjuvanted Pandemic Influenza Vaccines: Background Rate of Narcolepsy in Europe
Dieleman J, Lecomte C, Schuemie M, Van Rolleghem A, Hviid A, Svanstrom H, et al

Acceptability of HPV vaccination among young adults aged 18-30 years-a population based survey in Sweden
Sundstrom K, Tran Tn, Lundholm C, Young C, Sparen P, Dahlstrom La
VACCINE 2010;28(47):7492-500

Attitudes to HPV vaccination among parents of children aged 12-15 years-a population-based survey in Sweden
Dahlstrom La, Tran Tn, Lundholm C, Young C, Sundstrom K, Sparen P

Prospective study of human papillomavirus and risk of cervical adenocarcinoma
Dahlstrom La, Ylitalo N, Sundstrom K, Palmgren J, Ploner A, Eloranta S, et al

Prospective Study of Human Papillomavirus (HPV) Types, HPV Persistence, and Risk of Squamous Cell Carcinoma of the Cervix
Sundstrom K, Eloranta S, Sparen P, Dahlstrom La, Gunnell A, Lindgren A, et al

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia
Arnheim L, Dillner J, Sanjeevi Cb
TISSUE ANTIGENS 2005;65(3):252-9

Chlamydia trachomatis infection and persistence of human papillomavirus
Silins I, Ryd W, Strand A, Wadell G, Tornberg S, Hansson Bg, et al

HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses
Rollman E, Arnheim L, Collier B, Oberg D, Hall H, Klingstrom J, et al
VIROLOGY 2004;322(1):182-9

Visa alla publikationer